Gemphire Therapeutics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Gemphire Therapeutics General Information
Description
Developer of novel therapies designed to treat life threatening cardiovascular or metabolic and orphan diseases. The company is engaged in developing and commercializing therapies for patients with cardiometablic disorders including dyslipidemia and nash.
Contact Information
Primary Office
- 17199 North Laurel Park Drive
- Suite 401
- Livonia, MI 48152
- United States
Gemphire Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 30-Dec-2019 | 00000 | Completed | Generating Revenue | ||
| 6. Secondary Transaction - Private | 00000 | Completed | Generating Revenue | |||
| 5. PIPE | 04-Sep-2017 | 0000 | 00000 | 00000 | Completed | Generating Revenue |
| 4. PIPE | 10-Mar-2017 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 3. IPO | 04-Aug-2016 | 0000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 09-Mar-2016 | $10.6M | $10.6M | 0000 | Completed | Generating Revenue |
| 1. Angel (individual) | Completed | Generating Revenue |
Gemphire Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Gemphire Therapeutics Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Amherst Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Biobrit | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Biosciences Research and Commercialization Center | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BlueWater Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Capital Midwest Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
Gemphire Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NeuroBo Pharmaceuticals | 30-Jan-2020 | 0000000 00 | Biotechnology |
Gemphire Therapeutics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| NeuroBo Pharmaceuticals | 30-Jan-2020 | 0000000 000000 | Completed |
|